SciVision Biotech Inc
TWSE:1786
Income Statement
Earnings Waterfall
SciVision Biotech Inc
Revenue
|
713m
TWD
|
Cost of Revenue
|
-200.5m
TWD
|
Gross Profit
|
512.5m
TWD
|
Operating Expenses
|
-312.9m
TWD
|
Operating Income
|
199.6m
TWD
|
Other Expenses
|
-21.7m
TWD
|
Net Income
|
177.9m
TWD
|
Income Statement
SciVision Biotech Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
201
N/A
|
194
-3%
|
188
-3%
|
175
-7%
|
158
-9%
|
181
+14%
|
197
+9%
|
237
+20%
|
265
+12%
|
251
-5%
|
239
-5%
|
219
-8%
|
228
+4%
|
232
+1%
|
251
+8%
|
244
-3%
|
258
+6%
|
314
+21%
|
296
-6%
|
314
+6%
|
330
+5%
|
330
+0%
|
380
+15%
|
410
+8%
|
438
+7%
|
443
+1%
|
447
+1%
|
465
+4%
|
467
+0%
|
468
+0%
|
491
+5%
|
497
+1%
|
506
+2%
|
495
-2%
|
500
+1%
|
538
+8%
|
557
+4%
|
577
+4%
|
628
+9%
|
670
+7%
|
713
+6%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(85)
|
(83)
|
(80)
|
(78)
|
(79)
|
(85)
|
(90)
|
(103)
|
(109)
|
(107)
|
(104)
|
(97)
|
(101)
|
(103)
|
(108)
|
(105)
|
(106)
|
(112)
|
(102)
|
(109)
|
(113)
|
(119)
|
(134)
|
(135)
|
(132)
|
(127)
|
(124)
|
(123)
|
(124)
|
(122)
|
(135)
|
(151)
|
(164)
|
(175)
|
(178)
|
(183)
|
(185)
|
(185)
|
(193)
|
(199)
|
(200)
|
|
Gross Profit |
116
N/A
|
112
-4%
|
108
-3%
|
97
-10%
|
79
-18%
|
96
+21%
|
107
+12%
|
134
+25%
|
156
+16%
|
144
-8%
|
135
-7%
|
121
-10%
|
127
+5%
|
128
+1%
|
143
+12%
|
139
-3%
|
153
+10%
|
202
+32%
|
194
-4%
|
205
+6%
|
217
+6%
|
211
-3%
|
246
+17%
|
274
+11%
|
305
+11%
|
317
+4%
|
322
+2%
|
341
+6%
|
343
+1%
|
346
+1%
|
356
+3%
|
346
-3%
|
342
-1%
|
320
-6%
|
322
+1%
|
354
+10%
|
372
+5%
|
393
+6%
|
436
+11%
|
471
+8%
|
512
+9%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(86)
|
(89)
|
(94)
|
(98)
|
(115)
|
(115)
|
(119)
|
(126)
|
(115)
|
(116)
|
(111)
|
(103)
|
(99)
|
(101)
|
(113)
|
(116)
|
(122)
|
(134)
|
(129)
|
(134)
|
(136)
|
(141)
|
(147)
|
(157)
|
(171)
|
(171)
|
(183)
|
(193)
|
(197)
|
(206)
|
(209)
|
(211)
|
(220)
|
(215)
|
(224)
|
(231)
|
(237)
|
(233)
|
(261)
|
(289)
|
(313)
|
|
Selling, General & Administrative |
(60)
|
(63)
|
(66)
|
(66)
|
(78)
|
(78)
|
(85)
|
(95)
|
(91)
|
(92)
|
(87)
|
(77)
|
(69)
|
(68)
|
(76)
|
(76)
|
(82)
|
(91)
|
(84)
|
(87)
|
(88)
|
(89)
|
(99)
|
(108)
|
(128)
|
(128)
|
(135)
|
(141)
|
(137)
|
(144)
|
(146)
|
(146)
|
(154)
|
(150)
|
(161)
|
(174)
|
(185)
|
(184)
|
(217)
|
(245)
|
(259)
|
|
Research & Development |
(26)
|
(26)
|
(29)
|
(32)
|
(37)
|
(37)
|
(34)
|
(31)
|
(25)
|
(24)
|
(24)
|
(26)
|
(30)
|
(33)
|
(38)
|
(40)
|
(39)
|
(41)
|
(43)
|
(44)
|
(48)
|
(52)
|
(48)
|
(49)
|
(43)
|
(43)
|
(48)
|
(52)
|
(60)
|
(47)
|
(48)
|
(50)
|
(66)
|
(65)
|
(63)
|
(57)
|
(52)
|
(49)
|
(44)
|
(45)
|
(53)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(15)
|
(15)
|
(15)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
30
N/A
|
22
-25%
|
13
-40%
|
(2)
N/A
|
(35)
-1 980%
|
(19)
+47%
|
(12)
+38%
|
8
N/A
|
40
+384%
|
28
-30%
|
24
-16%
|
18
-26%
|
28
+57%
|
27
-3%
|
29
+9%
|
23
-23%
|
31
+38%
|
68
+118%
|
64
-6%
|
71
+11%
|
81
+13%
|
69
-14%
|
100
+43%
|
117
+18%
|
134
+14%
|
146
+9%
|
139
-5%
|
148
+7%
|
147
-1%
|
139
-5%
|
147
+5%
|
135
-8%
|
122
-10%
|
105
-14%
|
98
-6%
|
123
+25%
|
135
+9%
|
160
+19%
|
174
+9%
|
182
+4%
|
200
+10%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
4
|
5
|
8
|
10
|
13
|
9
|
6
|
13
|
6
|
4
|
4
|
(11)
|
(6)
|
(10)
|
(11)
|
(9)
|
(13)
|
(9)
|
(2)
|
0
|
3
|
6
|
1
|
(1)
|
(8)
|
(9)
|
(10)
|
(9)
|
(3)
|
(5)
|
(7)
|
(7)
|
(7)
|
2
|
7
|
15
|
8
|
1
|
7
|
15
|
9
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
31
|
31
|
31
|
29
|
1
|
0
|
1
|
|
Total Other Income |
(2)
|
(2)
|
(2)
|
(2)
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
(53)
|
(53)
|
(50)
|
(51)
|
3
|
7
|
5
|
5
|
13
|
9
|
9
|
9
|
4
|
8
|
9
|
13
|
15
|
9
|
8
|
4
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
|
Pre-Tax Income |
31
N/A
|
25
-19%
|
19
-26%
|
6
-68%
|
(22)
N/A
|
(10)
+57%
|
(5)
+49%
|
22
N/A
|
47
+116%
|
33
-31%
|
28
-14%
|
(45)
N/A
|
(31)
+31%
|
(33)
-5%
|
(32)
+1%
|
16
N/A
|
23
+39%
|
63
+180%
|
67
+6%
|
84
+25%
|
93
+11%
|
84
-10%
|
110
+31%
|
121
+10%
|
134
+11%
|
146
+9%
|
142
-2%
|
154
+9%
|
152
-1%
|
142
-7%
|
143
+1%
|
128
-11%
|
116
-10%
|
110
-5%
|
137
+25%
|
169
+23%
|
174
+3%
|
191
+10%
|
182
-5%
|
197
+8%
|
210
+7%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
9
|
9
|
7
|
0
|
0
|
0
|
0
|
0
|
8
|
8
|
8
|
8
|
5
|
5
|
5
|
5
|
(6)
|
(9)
|
(10)
|
(11)
|
(6)
|
(3)
|
(7)
|
(8)
|
(14)
|
(18)
|
(18)
|
(22)
|
(24)
|
(26)
|
(18)
|
(17)
|
(14)
|
(6)
|
(25)
|
(31)
|
(32)
|
(43)
|
(23)
|
(29)
|
(32)
|
|
Income from Continuing Operations |
40
|
34
|
26
|
6
|
(22)
|
(10)
|
(5)
|
22
|
55
|
41
|
36
|
(37)
|
(26)
|
(28)
|
(28)
|
21
|
17
|
55
|
58
|
73
|
87
|
81
|
103
|
112
|
121
|
127
|
124
|
133
|
128
|
116
|
126
|
112
|
102
|
104
|
112
|
138
|
142
|
148
|
159
|
168
|
178
|
|
Net Income (Common) |
40
N/A
|
34
-15%
|
26
-25%
|
6
-77%
|
(22)
N/A
|
(10)
+57%
|
(5)
+49%
|
22
N/A
|
55
+153%
|
41
-26%
|
36
-11%
|
(37)
N/A
|
(26)
+29%
|
(28)
-6%
|
(28)
+1%
|
21
N/A
|
17
-19%
|
55
+220%
|
58
+5%
|
73
+27%
|
87
+19%
|
81
-7%
|
103
+27%
|
112
+9%
|
121
+7%
|
127
+5%
|
124
-2%
|
133
+7%
|
128
-3%
|
116
-9%
|
126
+8%
|
112
-11%
|
102
-9%
|
104
+2%
|
112
+8%
|
138
+23%
|
142
+3%
|
148
+4%
|
159
+8%
|
168
+6%
|
178
+6%
|
|
EPS (Diluted) |
0.78
N/A
|
0.62
-21%
|
0.46
-26%
|
0.12
-74%
|
-0.4
N/A
|
-0.17
+58%
|
-0.08
+53%
|
0.41
N/A
|
0.97
+137%
|
0.76
-22%
|
0.67
-12%
|
-0.7
N/A
|
-0.44
+37%
|
-0.52
-18%
|
-0.51
+2%
|
0.41
N/A
|
0.28
-32%
|
1.04
+271%
|
1.09
+5%
|
1.34
+23%
|
1.42
+6%
|
1.34
-6%
|
1.58
+18%
|
1.72
+9%
|
1.71
-1%
|
1.95
+14%
|
1.75
-10%
|
1.87
+7%
|
1.95
+4%
|
1.64
-16%
|
1.77
+8%
|
1.45
-18%
|
1.43
-1%
|
1.57
+10%
|
1.69
+8%
|
2.07
+22%
|
1.89
-9%
|
2
+6%
|
2.13
+7%
|
2.25
+6%
|
2.32
+3%
|